About the Programme: One in three individuals will be diagnosed with cancer in their lifetime and it therefore represents a leading cause of mortality globally. Researchers and clinicians with expertise in this area are therefore in high demand. This MSc has been designed to help meet this demand by providing graduates with an in-depth knowledge and understanding of the causes and treatment of cancer from ‘bench-to-bedside’. Designed in close collaboration with clinicians and research specialists, this programme takes both a theoretical and practical approach to ensure it provides graduates with the specialist knowledge and skills required to pursue an academic career in cancer research as well as moving into the more applied fields of cancer treatments or hospital pathology. This MSc is studied full-time over one year, starting in September, and comprises two semesters of structured taught modules followed by an individual research project.
Programme Content: This MSc is delivered through a combination of lectures, expert seminars, state-of-the-art oncology-based practicals and projects supported by problem classes and tutorials. Laboratory-based work is an important part of the programme, which includes an extended oncology research project carried out in the research laboratory of an experienced cancer researcher. This MSc programme is designed to provide a highly supportive environment to students, where teamwork, project management and communication skills are as important as technical proficiency.
Core modules include the following subject areas:
Cellular and molecular biology of cancer Organ-specific cancers: bench-to-bedside Treatment of cancer Tumour immunology and microenvironment Oncology research skills Research project/dissertation.
Optional modules are available in the following subject areas:
Ethics in oncology/Clinical statistics Cancer and modifiable risks
Assessment: Students are assessed by a variety of methods including examinations, practicals, short reports, presentations and project work.
Special features: The programme is taught by cancer research-focussed staff. Excellent research environment and infrastructure in the recently completed £6 million, state-of-the-art, biomedical research facility housed in the Allam Building. Close collaborative links with the National Health Service, clinical physicians and clinical researchers who contribute to the development and delivery of the programme. This MSc provides students with the opportunity to become specialised in a focused area within oncology and can aid graduates in the decision to pursue academic cancer research or move into the more applied field of cancer treatments or hospital pathology.
Research areas The School’s research is structured around three major themes; biomedical sciences, evolutionary biology and ecology and environment. A major contributor to the biomedical sciences theme is the large core of cancer researchers, comprising almost 20 senior research leaders. Basic cancer biology, clinical oncology, cancer therapeutics, hypoxia and the tumour microenvironment, tumour metastasis, cancer genetics, radiobiology, tumour immunology, cancer diagnostics, energy metabolism, molecular and cancer PET imaging, cancer-related haemostasis and thrombosis and medicinal chemistry are just a number of the research specialties of the Cancer Research Group.
This Group has a long-standing interest in solid tumours, focussing on head, neck, brain, colorectal, oesophageal, breast, prostate, pancreatic and lung cancer. The Group works closely with colleagues at Castle Hill Hospital, the Hull York Medical School and the Department of Chemistry, with the aim of translating laboratory research into clinical practice. The research expertise of this Group feeds directly into the content and delivery of this MSc and therefore prepares students for progression onto PhD programmes as well as for employment in a variety of public sector bodies and industry.
You should have, or expect to obtain, a minimum of a 2:2 Honours degree in Biomedical Science (or equivalent). An IELTS overall score of 6.0 with a minimum of 5.5 in each component (or equivalent) is required of international students.
£5,600 (UK/EU) or £14,500 (International)
Recipient: University of Hull
Insert previous message below for editing?
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need. Why not add a message here